Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-09

Clinical Trial Update: H5N1 Vaccine Study in Japanese Adults [Phase 2, Phase 3]

View source ↗

Summary

The document reports completion of Phase 2 and Phase 3 trials of an H5N1 influenza vaccine in Japanese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • H5N1 influenza vaccine (influenza vaccine H5N1)

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: H5N1 Influenza | Phase 2, Phase 3 | Status: COMPLETED